Status:
NOT_YET_RECRUITING
A Journey Into Participation Patterns Among Patients With Hidradenitis Suppurativa
Lead Sponsor:
Power Life Sciences Inc.
Conditions:
Hidradenitis Suppurativa
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to uncover the factors driving patient decisions regarding enrollment, withdrawal, or re-engagement in hidradenitis suppurativa clinical trials. Understanding these factors will signif...
Eligibility Criteria
Inclusion
- Aged ≥ 18 years old
- Diagnosis of hidradenitis suppurativa
- Able to comprehend the investigational nature of the protocol and provide informed consent
Exclusion
- Female patients who are currently pregnant or nursing
- Inability to perform regular electronic reporting
- Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
Key Trial Info
Start Date :
January 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06201858
Start Date
January 1 2025
End Date
January 1 2027
Last Update
February 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Power Life Sciences
San Francisco, California, United States, 94107